Buy Ranbaxy Laboratories on dips, says Technical Analyst, Sudarshan Sukhani.

Sukhani told "Ranbaxy, I think this is a stock that you want to own on every dip and I see it go much higher. It seems to be in a hurry but that will stop. It will consolidate and will also correct."

He further said, ..

The Instanex FII Index was down 0.99% at 315.48% and the Instanex DII 15 portfolio was down 0.86%. Nifty was down 1.15% and Sensex was down 1.08%. The other Instanex Owner Indexes were also down - the Instanex Promoter 15 portfolio was down 1.03%, the Instanex Top 15 portfolio and the Instanex Retai..

BANGALORE: Sun Pharmaceutical Industries has got the US Food and Drug Administration's approval to launch its generic version of
GlaxoSmithKline's Imitrex tablets to treat migraine, the Indian drugmaker said.

Sun Pharma, India's largest drugmaker by market value, has also received US regulatory..

Sun Pharmaceutical Industries is top gainer on the Nifty. It has touched an intraday high of Rs 1,005 and an intraday low of Rs 965. At 1:33 pm, the share was quoting at Rs 1,003, up Rs 30.30, or 3.12%.